UDHQ Project Overview and Update 7 May 2012
|
|
- Baldwin Wilson
- 5 years ago
- Views:
Transcription
1 Introduction Organ, tissue, and eye (OTE) donation and transplantation professionals have long understood the value of collecting medical and behavioral history information on potential donors to assess infectious disease risk as well as determine factors that can affect quality of organ function or tissue utility. Testing today is greatly improved and valuable, both for detecting infectious diseases and understanding expected organ function, however, gaps remain (i.e., testing window periods, health history that assists with predicting organ functionality) that can be filled by collecting accurate information from the deceased donor s proxy historian. OTE donor medical and behavioral risk questionnaires have never been studied to assess comprehension or the formats being used, and they are known to be the root cause of mistakes. After reports of the successful development of a qualified blood donor questionnaire, the OTE donation community started the UDHQ-OTE Project to develop similar tools for screening donors for transplantation. The first drafts of interview questionnaires were developed by a multi-organizational Task Force that incorporated lessons learned from the blood donation community s experiences and from our own professionals involved with interviewing bereaved donor family members or others in close relationship to the donor. Two draft questionnaires were issued in December 2010 for public consultation and more than 500 comments were received. Evaluation of each comment was performed by a stakeholder review group with a final version for a donor >12 years old submitted to NCHS in late April The National Center for Health Statistics (NCHS) will evaluate the questions using cognitive interviewing techniques and field testing. The use of these forms will become widespread and training programs will be developed for those who use them. Project Overview The UDHQ-OTE Project is an acronym for the development of a Uniform Donor History Questionnaire for Organ, Tissue, and Eye donors that began, as a concept, in This project has been a major effort involving experienced professionals from organ, tissue, and ocular donation organizations and professional associations, as well as government agencies. Its purpose is to create qualified uniform donor history questionnaires, one for child donors and one for adult donors, with supporting documents for use by organ, tissue, and eye (OTE) donation professionals when screening for risk and determining suitability. Questionnaires currently used to screen OTE donors in the United States and Canada have problems similar to those identified by blood donation professionals. These include: content and formats have never been formally evaluated for effectiveness; use of questions that are not necessary and can be distracters; incorporation of many long, often compound, questions; inclusion of terminology and word phrases that the general public may not comprehend; and lack of standardization among organizations, which affects tissue and eye bank quality program review processes and interpretation of answers by organ transplant professionals. 1
2 Additionally, the Project takes into account special needs of the bereaved historian of a deceased donor. Primary aims are to reduce the complexity of the questionnaire while concurrently providing education to the historian to facilitate comprehension and to obtain accurate responses to risk assessment questioning by using more effective wording. Development During 2007, a multi-organizational 1 Uniform Donor History Questionnaire (UDHQ) Task Force was formed to begin work on a consensus questionnaire based on screening requirements of regulations and professional standards, best practices from the vast amount of experiences of members, and new concepts learned from the development of a universal blood donor questionnaire, as well as one for cellular therapy product donors, in the United States [1,2,3,4,5]. This new Task Force met periodically by conference call over the next 3 years. In November 2010, the development and subsequent validation of the UDHQ for transplant purposes was recognized and unanimously supported by an Advisory Committee to the Secretary of Health and Human Services (HHS): the Advisory Committee on Blood Safety and Availability (ACBSA). After discussion of transplant-related disease transmission events, this Committee determined there remain gaps in identifying the risk of disease involving donors of organs and tissues. To address it, the Committee recommended the Secretary support development and validation of a uniform donor health history, screening questionnaire. The Committee additionally recommended the development of a uniform questionnaire for donor screening to optimize patient safety. On December 1, 2010 the multi-organizational Uniform Donor History Questionnaire (UDHQ) Task Force released a draft version of a questionnaire to be used for an organ, tissue, or eye donor >12 years old, as well as one for a child donor, and requested constructive comments from professionals and the public. Incorporation of these questionnaires will prove to streamline this critical donor risk assessment process and increase satisfaction of all stakeholders involved in providing donor information (proxy historians), those administering the interviews, and those who review the answers to the donor risk assessment questions. These tools are expected to: optimize identification of suitable donors; minimize donor loss due to inappropriate rule out; and accurately identify an organ donor risk designation. Important background information was also provided and, before sending comments, submitters were directed to read it to gain a better understanding of the reasoning behind the order and construction of the questions (see Significant Notes: Questionnaire Structure and Content below). Through mid-january 2011, more than 500 comments were collected via a web link provided on the homepage of the American Association of Tissue Banks ( as well as by letters and . 1 The UDHQ-OTE Task Force included 70 members from organ procurement organizations, eye banks, tissue banks, non-transplant anatomical donation organizations, software companies, and representatives of the following: AATB, AOPO, CDC, EBAA, FDA/CBER, Health Canada, HRSA, NATCO, NHS/Scotland, and the NY State DoH. Twenty-five members regularly attended conference call discussions over a 3-year period. 2
3 In April 2011, a steering committee, the UDHQ Stakeholder Review Group, was formed to review these comments and finalize the forms. This included representatives from appropriate government agencies such as FDA/CBER, HRSA, CDC, and NCHS, as well as two OPTN/UNOS committees (DTAC, and the OPO Committee), and professional societies such as the AATB, AOPO, EBAA, NATCO, AST, and ASTS. A few members of the UDHQ Task Force comprise the remainder of this review group. They finalized a version of the Donor Risk Assessment Interview form for donors >12 years old after careful consideration of all the comments received. Officials from FDA/CBER offered a few final comments for improvement that were incorporated so the form was sure to meet federal expectations when screening donors of cells and/or tissues. The questions are designed to meet all requirements, which means compliance to requirements of regulations, laws and standards. The concepts surrounding how this can be done is optimized by use of broad-based capture questions, a process that assists with a respondent s understanding of questions asked. Further questioning to identify specific risks is only used when indicated. The DRAI form for donors> 12 years old will be further scrutinized by the foremost authority regarding development of effective, public health and behavioral history surveys. In Phase 1 during 2012, which is now being organized, the CDC s National Center for Health Statistics (NCHS) plans to perform a series of cognitive interviewing studies using the final version of the adult questionnaire. This is a qualitative evaluation of the questions and has been funded via an Interagency Agreement by the Office of Blood, Organ and Other Tissue Safety at CDC. Phase II is planned for 2013 and will comprise of field testing to obtain quantitative evaluation of the questions, however, funding sources for this phase remain to be identified. Significant Notes: Questionnaire Structure and Content This background information was provided during the on-line, public consultation period: Question order has been evaluated many times during development. The Task Force believes related risk assessments have been properly grouped and the concept of arranging them to place less recall stress on the donor s historian has been applied. Mental time travel starts with the present and flows backward sequentially through certain risk assessment time periods, ending with history ever. To reduce the number of time periods, some risk periods were expanded to allow grouping. In these cases, if a yes response to a capture question is received, the interviewer is reminded of the risk time period that applies and to ask more questions only if indicated. Although kept to a minimum, there is a question or two where risk screening redundancy occurs; entirely restricting screening for risk to one possible chance does not always occur (i.e., risks related to travel) and this is deliberate. Questions are constructed to be as short as possible but also gather necessary information to cover established national, state and association (standards) requirements; if your requirements are more stringent than these, re-evaluating the efficacy of requiring more 3
4 information should be pursued at your establishment. If differences in risk assessment continue, the process uniformity stakeholders have agreed upon will be in jeopardy. Use of she/he* in the questions appears awkward and this is on purpose. This consistently reminds the interviewer to mix the appropriate pronoun with other terms with which the historian can relate such as: the donor s given name; their nickname; or, by inserting your father, mother, husband, wife, sister, brother, daughter, son, or child (as indicated). By using this approach, the interviewer is afforded real-time instructions throughout administration of the questionnaire, versus simply using the donor or the deceased during the interview. A few questions include examples to educate the donor s historian regarding risk being assessed. For instance, in communication with federal authorities, defining sexual activity is expected if a capture question is used to initially assess this risk. The Task Force has developed an acceptable approach while also considering the sensitive nature of the topic. Additionally, providing examples van result in reducing the number of questions. The Risk Assessment Interview Questionnaire for a child donor was developed in response to numerous requests to develop one tailored to this unique donor population. It s intended for use for a donor who is 12 years of age or younger. Questionnaire versions (child and adult ) issued for comment were formatted to utilize a documentation method to circle responses. Checkbox versions of these questionnaires were also developed, and it is understood that electronic versions could additionally be formulated that offer another documentation method. Practice regarding the best documentation method to use was a topic that was further evaluated and the checkbox method is used in the final version. National training courses are planned to educate stakeholders regarding the background and rationale supporting the format and risk being assessed by asking each question. Additionally, work continues on: a User Instructions document that outlines expectations for the interviewer; easy to follow flowcharts for each question; and finalization of a DRAI for CHILD donors. References 1 Beatty P, Interview Evaluation of the Blood Donor History Screening Questionnaire, Results of a study conducted August-December, 2001, National Center for Health Statistics, Centers for Disease Control and Prevention %20Cognitive%20Evaluation%20final%20report%20NCHS%20v2.pdf 2 Orton S, Virvis V, Summary of Focus Group Discussions of Donor Screening Questions for Structure, Content and Comprehension, March %20UDHQ%20TF%20Focus%20Group%20Summary%20Final.pdf 4
5 3 Williams A, et al., Estimates of Infectious Disease Risk Factors in US Blood Donors, JAMA. 1997;277(12): Prepared by Scott A. Brubaker, CTBS UDHQ-OTE Project Chairperson May 7,
The TTSN - A Collaborative Biovigilance System
The TTSN - A Collaborative Biovigilance System 5th World Congress on Tissue Banking 12th International Conference of the APASTB Kuala Lumpur, Malaysia June 4, 2008 Scott A. Brubaker, CTBS American Association
More informationReport on the Transplantation Transmission Sentinel Network (TTSN)
Report on the Transplantation Transmission Sentinel Network (TTSN) CATB Session - AATB s 31st Annual Meeting, Boston September 15, 2007 Scott Brubaker, CTBS AATB Representative, TTSN Advisory Group TTSN
More informationDecember 20, Dear Dr. Frieden:
December 20, 2011 The Honorable Thomas Frieden, MD, MPH Director, Centers for Disease Control and Prevention 1600 Clifton Road, NE. Mailstop A-07 Atlanta, GA 30329 Ref: [Docket No. CDC-2011-0011]; Public
More informationOPTN/UNOS Ethics Committee Report to the Board of Directors June 1-2, 2015 Atlanta, GA. Peter Reese, MD, Chair Elisa Gordon, PhD, MPH, Vice Chair
OPTN/UNOS Ethics Committee Report to the Board of Directors June 1-2, 2015 Atlanta, GA Peter Reese, MD, Chair Elisa Gordon, PhD, MPH, Vice Chair Contents Action Items... 2 1. Ethical Principles to be Considered
More informationAbout kidney transplant care in New Zealand
About kidney transplant care in New Zealand A summary of the 2014 New Zealand Nephrology Activity Report: Kidney transplant care provided in 2014 1 ABOUT THIS REPORT This report is for people who have
More information9:00-9:30 Welcome and Update from Regional Councillor, Dr. Timothy M. Schmitt Non-Discussion Agenda (includes 5-10 minutes for voting preparation)
AGENDA OVERVIEW Region 8 Meeting Hilton Kansas City Airport 8801 NW 112 Street Kansas City, Missouri 64153 February 13 th, 2019 (Note: All times except the start time are approximate. Actual times will
More informationAd Hoc Disease Transmission Advisory Committee Report
Ad Hoc Disease Transmission Advisory Committee Report OPTN/UNOS Board of Directors Meeting Dr. Michael Green, MD, MPH, Chair Dr. Daniel Kaul, MD, Vice Chair June 23-24, 2014 PHS Guideline for Reducing
More informationUser Instructions Allogeneic HPC, Apheresis and HPC, Marrow Donor History Questionnaire. Table of Contents
User Instructions Allogeneic HPC, Apheresis and HPC, Marrow Donor History Questionnaire Table of Contents Purpose Introduction Capture Questions Methods of Administration DHQ Materials - Structure and
More informationUpdate of The National Vaccine Plan
Update of The National Vaccine Plan Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services Presentation Outline Statutory basis for the National Vaccine Program
More informationRegulatory Innovation: Not an Oxy-Moron. Alexandra K Glazier, Esq. President & CEO New England Donor Services
Regulatory Innovation: Not an Oxy-Moron Alexandra K Glazier, Esq. President & CEO New England Donor Services Disclosures CEO of New England Donor Services, running 2 OPOs (New England Organ Bank and LifeChoice
More informationUSER INSTRUCTIONS HPC, Cord Blood Donor History Questionnaire. Table of Contents
Page 1 of 9 USER INSTRUCTIONS HPC, Cord Blood Donor History Questionnaire Table of Contents Purpose Introduction Capture Questions Methods of Administration DHQ Materials Structure and Content Reformatting
More informationThe Organ and Tissue Donor Program
The Organ and Tissue Donor Program If I needed a kidney or some other vital organ to live Would I be able to get one? Maybe. Many people who need organ transplants cannot get them because of a shortage
More informationOpportunities for Organ Donor Intervention Research
Opportunities for Organ Donor Intervention Research Saving Lives by Improving the Quality and Quantity of Organs for Transplantation Webinar October 19, 2017 Committee Roster Committee on Issues in Organ
More informationUser Instructions Allogeneic HPC, Apheresis and HPC, Marrow Donor History Questionnaire. Table of Contents
User Instructions Allogeneic HPC, Apheresis and HPC, Marrow Donor History Questionnaire Table of Contents Purpose Introduction Methods of Administration DHQ Materials - Structure and Content Reformatting
More informationOverview and Findings from ASTHO s IIS Interstate Data Sharing Meeting
Overview and Findings from ASTHO s IIS Interstate Data Sharing Meeting Kim Martin Association of State and Territorial Health Officials (ASTHO) May 12, 2015 The Need for IIS Interstate Data Exchange States,
More informationNIDA Rationale Clean 1 09/17/06
Rationale for Modifications to the 2001 National Institute on Drug Abuse Policy on Counseling and Testing for HIV/AIDS and other Infectious Diseases (NOT-DA-01-001). This document identifies and provides
More informationHot Topics in Tissue Safety
Hot Topics in Tissue Safety 37 th Annual AATB Meeting National Harbor, Maryland 03 October 2013 Scott A. Brubaker, CTBS Chief Policy Officer PHS Guideline for Reducing Human Immunodeficiency Virus, Hepatitis
More informationTA L K I N G A B O U T T R A N S P L A N TAT I O N UNOS. Facts and. Figures
TA L K I N G A B O U T T R A N S P L A N TAT I O N UNOS Facts and Figures U N I T E D N E T W O R K F O R O R G A N S H A R I N G United Network for Organ Sharing The United Network for Organ Sharing (UNOS)
More information10:30-10:55 OPTN/UNOS Update, Maryl Johnson, MD, OPTN/UNOS Vice President. 10:55-12:00 Begin Discussion Agenda and OPTN/UNOS Committee Reports
AGENDA OVERVIEW Region 1 Meeting New England Donor Services 60 First Avenue, Waltham, MA 02451 February 11, 2019 (Note: All times except the start time are approximate. Actual times will be determined
More informationCurrent Infectious Disease Screening for the Live Organ Donor
2013 Public Health and Safety Guidelines for reducing HIV, HBV and HCV Transmission Though Organ Transplantation: Implications for Counseling and Disclosure Dianne LaPointe Rudow DNP, ANP-BC, CCTC Director
More informationDeveloping a Robust Aftercare Program
Developing a Robust Aftercare Program Amy Olszewski Donor Services Center Director AMAT September 24, 2015 Gift of Life Michigan is one of 58 federally designated organ and tissue recovery organizations
More information2015-Activities, Tissue Types and Inspections
2015-Activities, Tissue Types and Inspections Form Approved OMB No. 0990-0457 Exp. Date 06/30/2020 Welcome to the 2015 Activities Tissue Types and Inspections survey. Please refer to the following instructions
More informationTenant & Service User Involvement Strategy
Tenant & Service User Involvement Strategy Policy No: HM 07 Page: 1 of 9 Tenant & Service User Involvement Strategy 1. Introduction 1.1 Loreburn's Mission Statement is "Delivering Excellence" and we see
More informationNew York State Immunization Information System (NYSIIS) New York State Department of Health. Digital Government: Government to Business (G to B)
New York State Immunization Information System (NYSIIS) New York State Department of Health Digital Government: Government to Business (G to B) 1 Executive Summary The New York State Immunization Information
More informationPEARL Assessment Rubric
1 Outcome 1. Does the outcome clearly state what the target audience (e.g., students, staff, employers, etc.) will know and/or understand and/or do when they complete the program? 2. Does the outcome consistently
More informationPatient and Public Involvement in JPND Research
Patient and Public Involvement in JPND Research A user-friendly guide for applicants to JPND Calls for proposals January 5 2015 Created in conjunction with DenDRoN, United Kingdom Purpose The purpose of
More informationThe following four (4) consent forms represent the disposition choices available; please notarize the form that represents your disposition choice.
Dear Patient(s), Attached are the cryopreservation disposition forms you requested. Please read the following instructions carefully to facilitate completing this consent properly. Your consent must be
More informationOPTN/UNOS Membership and Professional Standards Committee (MPSC) Meeting Summary October 25-27, 2016 Chicago, Illinois
OPTN/UNOS Membership and Professional Standards Committee (MPSC) Meeting Summary October 25-27, 2016 Chicago, Illinois Jeffrey Orlowski, Chair Matthew Cooper, M.D., Vice Chair Discussions of the full committee
More informationGeneral Assembly. United Nations A/63/152/Add.1
United Nations General Assembly Distr.: General 8 May 2009 Original: English Sixty-third session Agenda items 41 and 124 Implementation of the Declaration of Commitment on HIV/AIDS and the Political Declaration
More informationMinnesota Administrative Uniformity Committee (AUC) Mission Statement, History and Governing Principles. June 2014
Mission Statement, History and Governing Principles 1. Definitions June 2014 For purposes of this document, the following definitions apply: 1.1. "Group purchaser" Group purchaser has the meaning given
More informationAdvisory Committee: A Report to the UNOS Board
Ad Hoc Disease Transmission Advisory Committee: A Report to the UNOS Board Emily A. Blumberg, MD Chair, /UNOS DTAC Shandie Covington UNOS Staff Liaison, DTAC June 28-29, 2011 Richmond, Virginia DTAC Action
More informationSecretary's Advisory Committee on Heritable Disorders in Newborns and Children May 13, 2009
Secretary's Advisory Committee on Heritable Disorders in Newborns and Children May 13, 2009 R. Rodney Howell Genetic Alliance Posted in the Resource Repository at: http://www.resourcerepository.org/documents/658/secretary'sadvisorycommitteeonh
More information10:55-12:00 Begin Discussion Agenda and OPTN/UNOS Committee Reports. 1:10-2:40 Conclude Discussion Agenda and OPTN/UNOS Committee Reports
AGENDA OVERVIEW Region 10 Meeting Radisson at the University of Toledo 3100 Glendale Ave Toledo, OH 43614 February 8, 2018 (Note: All times except the start time are approximate. Actual times will be determined
More informationGetting a New Kidney UHN. Information for patients and families. Is a kidney transplant right for me? Read this booklet to learn:
Getting a New Kidney UHN Information for patients and families Read this booklet to learn: about kidney transplants who can be donors how to start the transplant process how long the process might take
More informationDHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General , Hepatitis C Prevention and Control within Maryland
DHMH Activities toward Implementing Requirements of Md. Code Ann., Health-General 18-1001, Hepatitis C Prevention and Control within Maryland Submitted by: Maryland Department of Health and Mental Hygiene
More informationCommunity and Healthcare Preparedness Tools
Centers for Disease Control and Prevention Office of Public Health Preparedness and Response Community and Healthcare Preparedness Tools Jean Randolph, MPA, RN, FAAOHN Nurse Consultant NPAIHB 2018 Tribal
More informationState of Rhode Island. Medicaid Dental Review. October 2010
State of Rhode Island Medicaid Dental Review October 2010 EXECUTIVE SUMMARY The Centers for Medicare & Medicaid Services (CMS) is committed to improving pediatric dental care in the Medicaid program reflecting
More informationPROPOSED WORK PROGRAMME FOR THE CLEARING-HOUSE MECHANISM IN SUPPORT OF THE STRATEGIC PLAN FOR BIODIVERSITY Note by the Executive Secretary
CBD Distr. GENERAL UNEP/CBD/COP/11/31 30 July 2012 ORIGINAL: ENGLISH CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY Eleventh meeting Hyderabad, India, 8 19 October 2012 Item 3.2 of
More informationAs a result of this training, participants will be able to:
Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result
More informationCare and Social Services Inspectorate Wales. Care Standards Act Inspection Report. ategi Shared Lives Scheme. Cardiff
Care and Social Services Inspectorate Wales Care Standards Act 2000 Inspection Report ategi Shared Lives Scheme Cardiff Type of Inspection Focused Date of inspection Monday, 11 January 2016 Date of publication
More informationAs a result of this training, participants will be able to:
Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.
More informationDonate to research not involving embryonic stem cells
Columbia University Fertility Center 5 Columbus Circle PH Floor New York NY 10019 P: 212-314-8809 Fax: 212-314-8801 Email: fertility-lab@cumc.columbia.edu Dear Patient(s), Attached are the cryopreservation
More informationNATIONAL QUALITY FORUM
National Voluntary Consensus Standards for Patient Outcomes Summary of the Eye Care Technical Advisory Panel Conference Call March 25, 2010: 10:00-11:00PM Eastern Standard Time TAP members participating:
More informationChapter 9. Kidney Donors. ANZDATA Registry 37th Annual Report. Data to 31-Dec-2013
Chapter 9 Kidney Donors 214 37th Annual Report Data to 31-Dec-213 9-2 Deceased Kidney Donors The data for this section come from the Australia and New Zealand Organ Donor (ANZOD) Registry. Much more information
More informationAnswers to Your Questions about a Change in Kidney Allocation Policy What you need to know
Answers to Your Questions about a Change in Kidney Allocation Policy What you need to know Who are UNOS and the OPTN? The United Network for Organ Sharing (UNOS) is a nonprofit organization that operates
More informationRe-Envisioning OPTN/UNOS: HRSA Role as a Force for Innovation in Organ Transplantation
Re-Envisioning OPTN/UNOS: HRSA Role as a Force for Innovation in Organ Transplantation AST 2018 Cutting Edge of Transplantation 9 February 2018 Melissa A. Greenwald, M.D. CAPT U.S. Public Health Service
More informationInterventions in the Deceased Organ Donor to Improve Organ Quality and Quantity
Interventions in the Deceased Organ Donor to Improve Organ Quality and Quantity Sandy Feng, MD PhD Professor of Surgery University of California San Francisco Conflict of Interest Disclosure I have no
More informationUnderstanding How the U.S. Preventive Services Task Force Works USPSTF 101
Understanding How the U.S. Preventive Services Task Force Works USPSTF 101 1 2 Goals Improve understanding of the U.S. Preventive Services Task Force (USPSTF or Task Force) Explain the connection between
More informationProposal to Modify ABO Determination, Reporting, and Verifications Requirements. Operations and Safety Committee June 2015
Proposal to Modify ABO Determination, Reporting, and Verifications Requirements Operations and Safety Committee June 2015 1 The Problem Rules are misunderstood resulting in compliance issues Rules vary
More informationTHE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH ANONYMOUS DONOR SPERM
THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH ANONYMOUS DONOR SPERM Partner #1 Last Name (Surname): Partner #1 First Name: Partner
More informationNew York Center for Liver Transplantation Staff Report Annual Update 2011
New York Center for Liver Transplantation Staff Report Annual Update 2011 Strategic Planning: In January 2009 the Board of Directors conducted its first Strategic Planning meeting and in June adopted a
More informationChapter 8. Learning Objectives 9/10/2012. Research Principles and Evidence Based Practice
1 Chapter 8 Research Principles and Evidence Based Practice 2 Learning Objectives Explain the importance of EMS research. Distinguish between types of EMS research. Outline 10 steps to perform research
More informationUpdate on CDER s Drug Development Tool Qualification Program
Update on CDER s Drug Development Tool Qualification Program ShaAvhree Buckman-Garner, M.D., Ph.D. Director Office of Translational Sciences Center for Drug Evaluation and Research U.S. Food and Drug Administration
More informationWORLD HEALTH ORGANIZATION. Human organ and tissue transplantation
WORLD HEALTH ORGANIZATION EXECUTIVE BOARD EB113/14 113th Session 27 November 2003 Provisional agenda item 3.17 Human organ and tissue transplantation Report by the Secretariat 1. At its 112th session in
More informationHIV Housing Care Continuum Webinar 1 August 3, 2016
Page 1 HIV Housing Care Continuum August 3, 2016 Rita Flegel: Hello and welcome. I'm Rita Flegel, the Director of HUD's Office of HIV/AIDS Housing. And presenting with me today is Amy Palilonis also from
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL INTERIM REPORT 02_2013
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EXECUTIVE AGENCY FOR HEALTH AND CONSUMERS Health unit Contract number: 2010 21 02 Acronym: QUANDHIP INTERIM REPORT 02_2013 Proposal title: Quality
More informationPeer counselling A new element in the ET2020 toolbox
shutterstock Peer counselling A new element in the ET2020 toolbox Information Note. Main characteristics of the peer counselling tool Peer learning in the context of the education cooperation at EU level
More informationTypes of living donor transplants
TA L K I N G A B O U T T R A N S P L A N TAT I O N U N I T E D N E T W O R K F O R O R G A N S H A R I N G In response to the shortage of organs for transplantation, relatives, loved ones, friends, and
More informationBilling Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [60Day-12-12MW]
Billing Code: 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day-12-12MW] Proposed Data Collections Submitted for Public Comment and Recommendations In
More informationNHS public health functions agreement Service specification No.11 Human papillomavirus (HPV) programme
NHS public health functions agreement 2018-19 Service specification No.11 Human papillomavirus (HPV) programme 1 NHS public health functions agreement 2018-19 Service specification No.11 Human papillomavirus
More informationInternational Principles of Deceased Donor Organ Allocation
International Principles of Deceased Donor Organ Allocation The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation Accessed
More informationLocal Healthwatch Quality Statements. February 2016
Local Healthwatch Quality Statements February 2016 Local Healthwatch Quality Statements Contents 1 About the Quality Statements... 3 1.1 Strategic context and relationships... 5 1.2 Community voice and
More informationProposal: To remove organs from imminently dying patients before circulatory death.
Organ donation focus group guide Study overview: Problem: Many imminently dying patients who desire donation cannot successfully donate organs because not all patients with devastating injuries or life-limiting
More informationTHE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH IDENTIFIED DONOR SPERM
THE CENTER FOR ADVANCED REPRODUCTIVE SERVICES (CARS) (The Center) CONSENT TO PERFORM THERAPEUTIC DONOR INSEMINATION WITH IDENTIFIED DONOR SPERM Partner #1 Last Name (Surname): Partner #1 First Name: Partner
More information10:00-10:30 Welcome and Update from Regional Councillor, Todd Pesavento, MD Non-Discussion Agenda (includes 5-10 minutes for voting preparation)
AGENDA OVERVIEW Region 10 Meeting Radisson at the University of Toledo 3100 Glendale Ave Toledo, OH 43614 February 8, 2018 (Note: All times except the start time are approximate. Actual times will be determined
More informationFREQUENTLY ASKED QUESTIONS BONE MARROW / STEM CELL DONATION
FREQUENTLY ASKED QUESTIONS BONE MARROW / STEM CELL DONATION About Anthony Nolan Anthony Nolan is a pioneering charity that saves the lives of people with blood cancer who need a bone marrow, or stem cell,
More informationStanding Orders Protocols Increase Adult Immunizations
Standing Orders Protocols Increase Adult Immunizations William Atkinson, MD, MPH Associate Director for Immunization Education Immunization Action Coalition Saint Paul, Minnesota Immunization Action Coalition
More informationNATIONAL BLOOD TRANSFUSION SERVICES STRATEGY
FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA MINISTRY OF HEALTH NATIONAL BLOOD TRANSFUSION SERVICES STRATEGY February 2005 Addis Ababa Ethiopia Acknowledgement The Ministry of Health of the Federal Democratic
More informationConsiderations for Risk Associated with Zika Virus (ZIKV) Background Document
The following information will be used for a one-hour meeting on February 15, 20 of AATB s Tissue Transmitted Diseases Advisory Group (TTDAG), a subgroup of the Physicians Council. Questions: 1. Should
More informationImplementation: Public Hearing: Request for Comments (FDA-2017-N-6502)
March 16, 2018 via online submission: www.regulations.gov The Honorable Scott Gottlieb Commissioner Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Opioid Policy Steering
More information1:15-3:40 Conclude Discussion Agenda and OPTN/UNOS Committee Reports. 3:45 Estimated Adjournment (depending upon the amount of discussion)
AGENDA OVERVIEW Region 5 Meeting San Diego Marriott Mission Valley 8757 Rio San Diego Drive, San Diego, CA February 7, 2019 (Note: All times except the start time are approximate. Actual times will be
More informationCounting and Surveying Homeless Youth DC Alliance of Youth Advocates Washington, D.C.
Counting and Surveying Homeless Youth DC Alliance of Youth Advocates Washington, D.C. Overview Having an accurate count of homeless youth helps a community to understand the scope of the problem and to
More informationAODA Integrated Accessibility Standards Regulation (IASR) Information and Communications Policy
AODA Integrated Accessibility Standards Regulation (IASR) Information and Communications Policy Intent This policy is intended to meet the requirements of the Integrated Accessibility Standards, Ontario
More informationUK National Screening Committee. Gaucher Disease Screening in Newborn. 26 November 2014
UK National Screening Committee Gaucher Disease Screening in Newborn 26 November 2014 Aim 1. This document provides background on the item addressing Gaucher disease. Current policy 2. This is the first
More information2. ORGANIZATIONAL READINESS
Building Blocks to Peer Program Success 2. ORGANIZATIONAL READINESS STATE OR LOCAL HEALTH DEPT Are you ready for a peer program? The tools in this section can be used by health departments (state or local)
More informationGRANGE PARK SURGERY LOCAL PATIENT PARTICIPATION REPORT
GRANGE PARK SURGERY LOCAL PATIENT PARTICIPATION REPORT Date: February 2012 1. Introduction The Patient Participation Group (PPG) at Grange Park Surgery was established in 2009 with the first open meeting
More informationNebraska Statewide Suicide Prevention Plan
Nebraska Statewide Suicide Prevention Plan 2016-2020 This plan provides a framework to help Nebraskans work together to prevent suicide. It sets out shared strategies for suicide prevention and sets the
More information2015 NAIIS Summit Quality Measures May 12, 2015
2015 NAIIS Summit Quality Measures May 12, 2015 Sharon L. Sprenger Co-Lead Quality Measures Workgroup Director, Measurement Coordination and Outreach Division Healthcare Quality Evaluation The Joint Commission
More informationGlobal Harmonization Task Force SG3 Comments and Recommendations ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO and 13488
Page 1 of 6 Global Harmonization Task Force SG3 ISO/DIS 9001: 2000 and ISO/DIS 9000: 2000 And Revision of ISO 13485 and 13488 GENERAL COMMENTS The Global Harmonization Task Force Study Group Three (GHTF
More informationThe National Vaccine Advisory Committee: Reducing Patient and Provider Barriers to Maternal Immunizations
The National Vaccine Advisory Committee: Reducing Patient and Provider Barriers to Maternal Immunizations Executive Summary Maternal immunization provides important health benefits for pregnant women and
More informationDemocratizing Science: Processes for the involvement of the public in scientific. issues and their success
Courtesy of. Used with permission. Democratizing Science: Processes for the involvement of the public in scientific issues and their success Globalization, and thus the interconnectedness and interdependence
More informationUpdating Primary Kidney Transplant Physician Requirements OPTN/UNOS Membership and Professional Standards Committee
Updating Primary Kidney Transplant Physician Requirements OPTN/UNOS Membership and Professional Standards Committee Prepared by: Chad Waller UNOS Member Quality Department Contents Executive Summary 1
More informationThe Kidney Exchange Problem
100 The UMAP Journal 28.2 (2007) The Kidney Exchange Problem Transplant Network Despite the continuing and dramatic advances in medicine and health technology, the demand for organs for transplantation
More informationMeasuring outcomes to improve the management of continence care. Dr Adrienne Rivlin KPMG Global Strategy Group
Measuring outcomes to improve the management of continence care Dr Adrienne Rivlin KPMG Global Strategy Group Background of the study Many treatment options, few find a cure High quality daily continence
More informationDE LA SALLE UNIVERSITY. Checklist A Research Ethics Checklist for Investigations involving Human Participants
DE LA SALLE UNIVERSITY Checklist A Research Ethics Checklist for Investigations involving Human Participants This checklist must be completed AFTER the De La Salle University Code of Research Ethics and
More informationA Strategy for Evaluating ICD-10 Implementation and Updating Process: 2005 Status Report
WHO-FIC NETWORK MEETING Recommendations Marjorie S. Greenberg, Head, North American Collaborating Center National Center for Health Statistics, Centers for Disease Control and Prevention, Hyattsville,
More informationComprehensive Cancer Control Technical Assistance Training and Communication Plan. PI: Mandi Pratt-Chapman, MA. Cooperative Agreement #1U38DP
Comprehensive Cancer Control Technical Assistance Training and Communication Plan PI: Mandi Pratt-Chapman, MA Cooperative Agreement #1U38DP004972-01 July 2014 Acknowledgement: This work was supported by
More informationUsing Routine Health Information to Improve Voluntary Counseling and Testing in Cote d Ivoire
Using Routine Health Information to Improve Voluntary Counseling and Testing in Cote d Ivoire Data Demand and Information Use Case Study Series MEASURE Evaluation www.cpc.unc.edu/measure Data Demand and
More informationOrgan Transplantation Program Update
Organ Transplantation Program Update March 7, 2013 Christopher J. McLaughlin Chief, Organ Transplantation Branch Division of Transplantation Department of Health and Human Services Health Resources and
More informationQUALITY IMPROVEMENT TOOLS
QUALITY IMPROVEMENT TOOLS QUALITY IMPROVEMENT TOOLS The goal of this section is to build the capacity of quality improvement staff to implement proven strategies and techniques within their health care
More informationHCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report
HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report About HCV Action HCV Action is a network, co-ordinated by The Hepatitis C Trust, that brings together health professionals
More informationICD-10 Open Discussion
ICD-10 Open Discussion Presentation to: Providers, Trading Partners and Billing Firms Presented by: Camillia Harris, ICD-10 Communications Lead Erica Baker, ICD-10 Communications Consultant October 29,
More informationFollowing a Telephone Survey with a Mail Survey
Following a Telephone Survey with a Mail Survey Katrina Wynkoop Simmons, Ph.D. BRFSS Coordinator Center for Health Statistics Washington State Department of Health 6 th Annual Regional Training Workshop
More informationPandemic Influenza Preparedness and Response
Pandemic Influenza Preparedness and Response US Department of Health and Human Services Bruce Gellin, MD, MPH Director, National Vaccine Program Office The pandemic influenza clock is ticking. We just
More informationRetention is Key A Program to Increase Membership Note: Adapted from RI Retention Pilot Program as amended by District 5230
Retention is Key A Program to Increase Membership Note: Adapted from RI Retention Pilot Program as amended by District 5230 Implementing the following seven steps with dedication and club leadership has
More informationUNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision
UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a
More informationA Framework for Optimal Cancer Care Pathways in Practice
A to Guide Care Cancer Care A for Care in Practice SUPPORTING CONTINUOUS IMPROVEMENT IN CANCER CARE Developed by the National Cancer Expert Reference Group to support the early adoption of the A to Guide
More information510(k) submissions. Getting US FDA clearance for your device: Improving
Getting US FDA clearance for your device: Improving 510(k) submissions Audrey Swearingen, RAC Director, Regulatory Affairs Telephone: +1 512.222.0263 Email: aswearingen@emergogroup.com Download this white
More informationIncreasing Adult Immunization Rates in the US Through Data and Quality: A Roadmap
Increasing Adult Immunization Rates in the US Through Data and Quality: A Roadmap Avalere Health An Inovalon Company November 16, 2017 In Partnership with GSK Agenda 1 2 3 4 5 Welcome & Introductions Overview:
More information